U.S., Oct. 21 -- ClinicalTrials.gov registry received information related to the study (NCT07217990) titled 'Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer' on Oct. 15.
Brief Summary: This study will evaluate the efficacy and non-inferiority of a non-surgical approach for the treatment of patients with locally advanced breast cancer.
Study Start Date: Dec. 15
Study Type: INTERVENTIONAL
Condition:
Breast Cancer
HER2-positive Breast Cancer
Triple Negative Breast Cancer
Intervention:
DRUG: Neoadjuvant Chemotherapy
Participants will receive standard of care neoadjuvant chemotherapy
RADIATION: Radiation Therapy
Radiotherapy simulation parameters will be at the discretion of the tr...